Sanofi Accused Of Fraud In Clinical Trial Of Drug

Law360 (February 15, 2008, 12:00 AM EST) -- Allegations that Sanofi-Aventis Pharmaceuticals deliberately concealed potential harmful effects of its antibiotic Ketek, which has been linked to liver damage, continued to pile up Tuesday as the U.S. House Committee on Energy and Commerce heard more witnesses.

Ana Marie Cisneros, a clinical research associate who worked for one of the doctors contracted by Sanofi to run tests, said that her supervisor and Sanofi worked together to defraud the U.S. Food and Drug Administration by fabricating patients in a 400-person study.

Cisneros said that while working for the doctor, who has since pled guilty to the fraud, she noticed that the trial...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS